EMA To Tackle Inconsistencies In Quality Data For Drug-Device Combinations
Executive Summary
The European Medicines Agency believes guidance is needed on the quality aspects of drug-device combinations to show that these products are appropriately designed and can be used correctly in their intended clinical situations.